IL6 and cancer: Zhou et al. found that plasma IL-6 and TNF-α levels correlated significantly with graded changes in limited PCa 118 and that the downstream molecule of IL-6, STAT-3 inhibitor Stt, and anti-IL-6R antibody Tcz combined to target tumor cells exhibited anti-cancer effects 119.